MR-HIFU opens up non-invasive alternatives to traditional surgical treatments of uterine fibroids and enables non-invasive palliative pain treatment of bone metastases.
It is an innovative therapy platform that integrates an advanced High Intensity Focused Ultrasound (HIFU) system into the patient table of Philips MRI systems. This allows you to perform non-invasive HIFU therapy supported by advanced planning and temperature monitoring using MR imaging.
The Sonalleve high frequency focused ultrasound uses a special transducer to focus a beam of ultrasound waves on to the fibroid located within the body. The focused ultrasound waves generate high temperatures within smaller areas. The temperature when maintained for sufficient a period of time results in the ablation of the fibroids.
The therapy procedure guided by Magnetic Resonance Imaging (MRI) with real time feedback helps in the focused ablation of the target location. The real-time feedback loop ensures that adequate heating takes place, treating every bit of tissue that has been targeted and volumetric ablation (a Philips proprietary technology) helps treat larger volumes efficiently and quickly.